🔎 Trials Near Me

Utama › Keadaan Pasca-COVID (Long COVID) › Kentucky

Kajian klinikal Keadaan Pasca-COVID (Long COVID) di Kentucky

6 kajian untuk Keadaan Pasca-COVID (Long COVID) sedang mencari peserta di lokasi di Kentucky.

Bandar di Kentucky

Teks kajian rasmi (Bahasa Inggeris)

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

  • University of Louisville School of Medicine ( Site 3706), Louisville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06667700

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Louisville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450

A Study of COVID-19 Vaccine(s) in Children and Adults

  • Kentucky Pediatric /Adult Research, Bardstown
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
Umur 5 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07798648

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • UL International Travel Clinic, Louisville
  • University of Louisville Hospital, Louisville
  • University of Louisville School of Medicine, Louisville
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

  • University of Kentucky, Lexington
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Mei 2026 · NCT05218083

Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID

  • University of Louisville Outpatient Care Center, Louisville
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Mac 2025 · NCT06883513

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.